|
Pei, Z; Sebti, S M (1996) Cys102 and His398 are required for bleomycin-inactivating activity but not for hexamer formation of yeast bleomycin hydrolase. Biochemistry 35:10751-6
|
|
Pei, Z; Calmels, T P; Creutz, C E et al. (1995) Yeast cysteine proteinase gene ycp1 induces resistance to bleomycin in mammalian cells. Mol Pharmacol 48:676-81
|
|
Morris, G; Mistry, J S; Jani, J P et al. (1992) Neutralization of bleomycin hydrolase by an epitope-specific antibody. Mol Pharmacol 42:57-62
|
|
Jani, J P; Mistry, J S; Morris, G et al. (1992) In vivo circumvention of human colon carcinoma resistance to bleomycin. Cancer Res 52:2931-7
|
|
Jani, J P; Mistry, J S; Morris, G et al. (1992) In vivo sensitization of human lung carcinoma to bleomycin by the cysteine proteinase inhibitor E-64. Oncol Res 4:59-63
|
|
Mistry, J S; Jani, J P; Morris, G et al. (1992) Synthesis and evaluation of fluoromycin: a novel fluorescence-labeled derivative of talisomycin S10b. Cancer Res 52:709-18
|
|
Sebti, S M; Jani, J P; Mistry, J S et al. (1991) Metabolic inactivation: a mechanism of human tumor resistance to bleomycin. Cancer Res 51:227-32
|
|
Morris, G; Mistry, J S; Jani, J P et al. (1991) Cysteine proteinase inhibitors and bleomycin-sensitive and -resistant cells. Biochem Pharmacol 41:1559-66
|
